Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania.
Drug discovery pipelines for the "neglected diseases" are now heavily populated with nitroheterocyclic compounds. Recently, the bicyclic nitro-compounds (R)-PA-824, DNDI-VL-2098 and delamanid have been identified as potential candidates for the treatment of visceral leishmaniasis. Using a...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-11-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC5094698?pdf=render |